Disclosures for "Impact of natalizumab on chronic active lesions")
-
Ms. Nylund has nothing to disclose.
-
Markus Matilainen has nothing to disclose.
-
Dr. Sucksdorff has nothing to disclose.
-
Mr. Polvinen has nothing to disclose.
-
Dr. Airas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Airas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Airas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Airas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.